 SAN DIEGO, Sept. 9, 2021 PRNewswire -- Regulus Therapeutics Inc. Nasdaq: RGLS, a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs the Company or Regulus, today announced that Jay Hagan, President and Chief Executive Officer of Regulus, will present at the H.C. 